Quantcast

Latest Prenatal diagnosis Stories

2014-04-29 23:05:57

New American Heart Association guidelines on diagnosis and treatment of fetal cardiac disease seek to improve care for babies with congenital heart disease. Philadelphia, Pa. (PRWEB) April 29, 2014 The important guidelines released by the AHA recently aim to improve care for babies with congenital heart disease while they are in the womb. Congenital heart defects are the most common birth defects, affecting one in 120 babies. As a leading Cardiac Center in the U.S., and renowned...

2014-03-26 16:25:15

DUBLIN, March 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3gb8bq/prenatal_and) has announced the addition of the "Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" [http://www.researchandmarkets.com/research/3gb8bq/prenatal_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Genetic testing is a...

2014-03-24 08:27:17

ALBANY, New York, March 24, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Prenatal and Newborn Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global prenatal and newborn genetic testing market was valued USD 1.12 billion in 2012 and expected to grow at a CAGR of 26.9% from 2013 to 2019, to reach an estimated value of USD 8.37 billion...

2014-03-19 04:21:22

DUBLIN, March 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tdmwb8/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Report" [http://www.researchandmarkets.com/research/tdmwb8/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal testing is increasingly being adopted by high risk pregnant women for the...

2014-03-13 08:29:57

SAN JOSE, Calif., March 13, 2014 /PRNewswire/ -- Ariosa Diagnostics, Inc., maker of the Harmony(TM) Prenatal Test, announced today that it has tested over 45,000 pregnant women in the fourth quarter of 2013 continuing the rapid adoption of the Harmony test as a safe, highly accurate and affordable alternative to current prenatal screening tests. Ariosa has received patient samples from over 50 countries worldwide. http://photos.prnewswire.com/prnvar/20130225/SF62999LOGO Ariosa also...

2014-02-24 16:23:58

NORWALK, Conn., Feb. 24, 2014 /PRNewswire/ -- UBM Medica US announces that OBGYN.net, a leading online community for medical professionals specializing in women's health, will be featuring special coverage of key study findings and exhibitor presentations from the Society for Maternal-Fetal Medicine's 34(th) annual meeting, The Pregnancy Meeting(TM), that was held February 3-8 in New Orleans. The Society for Maternal-Fetal Medicine gathers each winter for The Pregnancy Meeting to share the...

2014-02-12 08:30:24

SAN JOSE, Calif., Feb. 12, 2014 /PRNewswire/ -- Ariosa Diagnostics, Inc., maker of the Harmony(TM) Prenatal Test has received approval from the New York Department of Health, Division of Laboratory Quality Certification, to offer, market and report results of the Harmony test to healthcare providers in the State of New York. According to state statistics from 2011, New York reported over 362,000 pregnancies, underscoring the significant number of potential patients in New York who may...

2014-02-08 23:00:50

Fetal Surgeons Treat Twin-Twin Transfusion Syndrome in Utero Philadelphia and New Orleans (PRWEB) February 08, 2014 Monochorionic twins who underwent in utero laser surgery for a life-threatening diagnosis are likely to show normal neurodevelopmental development at age 2, according to fetal medicine experts. Maternal-fetal medicine and clinical genetics specialist Nahla Khalek, MD, of the Center for Fetal Diagnosis and Treatment at The Children’s Hospital of Philadelphia (CHOP),...

2014-01-28 04:21:06

SAN JOSE, Calif. and LONDON, Jan. 28, 2014 /PRNewswire/ -- A team of clinical researchers from The Harris Birthright Centre for Fetal Medicine is leading a study to evaluate the implementation of cell-free DNA testing using the Harmony(TM) Prenatal Test in the UK screening population of 700,000 women per year. While the Harmony test is available throughout the UK, it is being offered only through private clinics where women pay directly for the test themselves. The Harmony test...

2014-01-20 23:04:14

GIA announces the release of a trend report on Advancements in Prenatal Screening. Strong government investments and legislation of incentive measures are projected to drive advancements in prenatal screening. San Jose, California (PRWEB) January 20, 2014 Follow us on LinkedIn – Prenatal diagnosis, also referred to as prenatal screening, is a procedure for investigating diseases or conditions in an embryo or fetus. In addition to identifying possible birth defects, prenatal screening...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.